Dr. Iberri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
# Stanford
Stanford, CA 94305Phone+1 650-498-4560
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2013 - 2016- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2013
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2010 - 2011
University of Vermont College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2011 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma.Hitomi Hosoya, Mia Carleton, Kailee Tanaka, Brian Sworder, Shriya Syal
Nature Communications. 2025-02-20 - MGCS: where do we stand today?David Iberri, Michaela Liedtke
Hematology. American Society of Hematology. Education Program. 2024-12-06 - Clonality Determination by Detecting Unmodified Monoclonal Serum Free Light Chains Using On-Probe Extraction Coupled with Liquid Chromatography-High-Resolution Mass Sp...Priscilla S W Yeung, Yajing Liu, Samuel Yang, Ashley Ruan, Christina R Kerr
Clinical Chemistry. 2024-12-02
Press Mentions
Evaluating Selinexor in Patients with Relapsed/Refractory DLBCLSeptember 1st, 2020
Has the FDA Been Approving Some Drugs Without Proper Evidence?August 20th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
